CSE: BUX | OTCQB: BMKDF | FSE: 20B
CSE: BUX | OTCQB: BMKDF | FSE: 20B
The information on this page and throughout this website is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, sell, or hold any securities of BioMark Diagnostics Inc.
Nothing on this website constitutes an offer to sell or a solicitation of an offer to buy any securities. BioMark Diagnostics Inc. is a reporting issuer in Canada. Investors are strongly encouraged to review the company’s complete public filings, including risk factors, on SEDAR+ before making any investment decision.
This page may contain forward-looking statements within the meaning of applicable Canadian securities legislation. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investing in securities involves significant risk, including the possible loss of principal. BioMark disclaims any obligation to update forward-looking information except as required by law.
Please consult with a qualified financial advisor before making any investment decisions. All figures are in Canadian dollars unless otherwise stated.
September 2025 (Current)
Contact us for further information.
BioMark updates its Corporate Presentation regularly. Please be sure to check this page for the latest version.